In episode 20 of the Ori Spotlight Podcast, Jason C. Foster is joined by Jason Bock, CEO at CTMC (a joint venture between Resilience and MD Anderson Cancer Center) as they discuss bringing advanced therapies to patients at scale. Jason has also recently joined Ori as a member of our SAB – we’re honored to have Jason’s expertise and insights support us in achieving our mission.
Jason Bock has substantial experience in biopharmaceutical development, where he has previously held senior positions at Teva Pharmaceuticals and MD Anderson. He now leads CTMC (Cell Therapy Manufacturing Center) – a joint venture between Resilience and MD Anderson Cancer Center, that was created to better enable innovation from academia and biotech, and accelerate the impact of cell therapy for patients.
Together, they both share their insights into the digitalization of CGT manufacturing, how we can overcome challenges within the CGT industry and how we can support the industrialization of novel advanced therapies.
Learn more about: